Novo Nordisk Ends Heart Disease Drug Trials in Fresh Setback

Novo Nordisk A/S stopped two more trials for its experimental heart disease medicine, in a further blow to the drug’s prospects.

By Ashleigh Furlong · Bloomberg

Novo Nordisk A/S stopped two more trials for its experimental heart disease medicine, in a further blow to the drug’s prospects.